rubitecan has been researched along with Leukemia, Myeloid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharti, A; Giovanella, B; Kufe, D; Pantazis, P; Rubin, E; Toppmeyer, D | 1 |
| Early, JA; Giovanella, BC; Kozielski, AJ; Mendoza, JT; Natelson, EA; Pantazis, P | 1 |
| DeJesus, A; Early, J; Giovanella, B; Pantazis, P | 1 |
3 other study(ies) available for rubitecan and Leukemia, Myeloid
| Article | Year |
|---|---|
Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Camptothecin; Cell Line; Cell Nucleus; Cell Survival; Clone Cells; Codon; DNA Primers; DNA Topoisomerases, Type I; DNA, Complementary; Drug Resistance; Humans; Kinetics; Leukemia, Myeloid; Mice; Molecular Sequence Data; Molecular Weight; Point Mutation; Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Tumor Cells, Cultured | 1994 |
9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Cycle; Cell Death; DNA, Neoplasm; Growth Inhibitors; Humans; In Vitro Techniques; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1993 |
Altered sensitivities to anticancer and differentiation agents in etoposide-resistant human myeloid leukemia U-937 cells.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cell Differentiation; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, Myeloid; Lymphotoxin-alpha; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |